mcas and semaglutide New research highlights the use of #GLP1 receptor agonists (like & tirzepatide) in treating mast cell activation syndrome (MCAS). In this case series, patients reported: • Rapid symptom relief (fatigue, brain Spotlight on the Mechanism of

The views expressed in this post are the author's own, and the information presented has not been verified by Patch

They feed gut bacteria, which create short-chain fatty acids natural compounds that calm inflammation and stimulate natural GLP-1 release

Red Clover Flower Extract: Contains isoflavones that promote hormonal balance, particularly relevant for women in perimenopause or menopause who are also on GLP-1 medications

The core composition patent extends to December 2031, with additional patents running through 2033

Patients should discuss treatment duration expectations with their healthcare provider

Prescription copy, original pharmacy packaging, and a GP letter if you have one